A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

Ochsner's national study with The GRAIL Galleri® test is finding at least one hidden cancer a week in unsuspecting people. “I fully believe that in five, maybe 10 years, it will be routine to go to ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

While the method shows promise, some experts say that other self-collection devices are more readily available ...

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...